{"DataElement":{"publicId":"5782346","version":"1","preferredName":"Bone Marrow Percent Unit Neoplasm Involved Number","preferredDefinition":"Information related to the percentage of bone marrow involvement","longName":"BM_PCT_NPL_INVLD_NMB","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5731886","version":"1","preferredName":"Bone Marrow Percent Unit Neoplasm Involved","preferredDefinition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes._A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred)._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Involved; connected by participation or association or use.","longName":"2176966v1.0:5731884v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2176966","version":"1","preferredName":"Bone Marrow","preferredDefinition":"The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells (MSH98)","longName":"Bone Marrow","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Bone Marrow","conceptCode":"C12431","definition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A26-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5731884","version":"1","preferredName":"Percent Unit Neoplasm Involved","preferredDefinition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Involved; connected by participation or association or use.","longName":"C48570:C3262:C25547","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Involved","conceptCode":"C25547","definition":"Involved; connected by participation or association or use.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C4CEEF3-B5F9-104C-E053-F662850A46F5","latestVersionIndicator":"Yes","beginDate":"2017-04-03","endDate":null,"createdBy":"CHANGP","dateCreated":"2017-04-03","modifiedBy":"ONEDATA","dateModified":"2017-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C4CEEF3-B60A-104C-E053-F662850A46F5","latestVersionIndicator":"Yes","beginDate":"2017-04-03","endDate":null,"createdBy":"CHANGP","dateCreated":"2017-04-03","modifiedBy":"MAESKEB","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5782341","version":"1","preferredName":"Percentage Neoplasm Involvement Number","preferredDefinition":"A fraction or ratio with 100 understood as the denominator._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._To have a connection by participation or association or use; sharing in an activity or process._A numeral or string of numerals expressing value, quantity, or identification.","longName":"5782341v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"> 5%, specify","valueDescription":"Greater Than Five Percentage Specify","ValueMeaning":{"publicId":"5782342","version":"1","preferredName":"Greater Than Five Percentage Specify","longName":"5782342","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.: A fraction or ratio with 100 understood as the denominator.: Be specific about something; define clearly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Five","conceptCode":"C66836","definition":"A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E1A33BC-CD99-5E87-E053-F662850A8DBF","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E1A33BC-CDB2-5E87-E053-F662850A8DBF","beginDate":"2017-04-26","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"},{"value":"> 0 to </= 5%","valueDescription":"Greater Than Zero To Less Than Or Equality Five Percentage","ValueMeaning":{"publicId":"5791742","version":"1","preferredName":"Greater Than Zero To Less Than Or Equality Five Percentage","longName":"5791742","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.: Used as a function word to indicate direction, purpose, or movement.: A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The quality of being the same in quantity or measure or value or status.: A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.: A fraction or ratio with 100 understood as the denominator.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Zero","conceptCode":"C70430","definition":"A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Equality","conceptCode":"C61582","definition":"The quality of being the same in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Five","conceptCode":"C66836","definition":"A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E2B8686-70A1-358D-E053-F662850AB6D3","latestVersionIndicator":"Yes","beginDate":"2017-04-27","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E2CAB87-9823-7083-E053-F662850AC4B5","beginDate":"2017-04-27","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-27","modifiedBy":"ONEDATA","dateModified":"2017-04-27","deletedIndicator":"No"},{"value":"No tumor infiltration","valueDescription":"No Neoplasm Infiltration","ValueMeaning":{"publicId":"6624847","version":"1","preferredName":"No Neoplasm Infiltration","longName":"6624847","preferredDefinition":"The non-affirmative response to a question.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: The process of the diffusion or accumulation in a tissue or cells of a substance not normal to it or in amounts above normal. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infiltration","conceptCode":"C25754","definition":"The process of the diffusion or accumulation in a tissue or cells of a substance not normal to it or in amounts above normal. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80C4EA4B-22F1-5DE4-E053-F662850AA95B","latestVersionIndicator":"Yes","beginDate":"2019-01-31","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-31","modifiedBy":"ONEDATA","dateModified":"2019-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"80C4EA4B-230C-5DE4-E053-F662850AA95B","beginDate":"2019-01-31","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-31","modifiedBy":"ONEDATA","dateModified":"2019-01-31","deletedIndicator":"No"},{"value":"> 0 to ≤ 5%","valueDescription":null,"ValueMeaning":{"publicId":"14741315","version":"1","preferredName":"> 0 to ≤ 5%","longName":"14741315v1.00","preferredDefinition":"> 0 to ≤ 5%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"105A96F5-953C-770E-E063-731AD00A8B08","latestVersionIndicator":"Yes","beginDate":"2024-02-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-01","modifiedBy":"MMADDINENI","dateModified":"2024-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"105A96F5-953D-770E-E063-731AD00A8B08","beginDate":"2024-02-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-01","modifiedBy":"MMADDINENI","dateModified":"2024-02-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5782340","version":"1","preferredName":"Percentage Neoplasm Involvement Number","preferredDefinition":"A fraction or ratio with 100 understood as the denominator.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:To have a connection by participation or association or use; sharing in an activity or process.:A numeral or string of numerals expressing value, quantity, or identification. ","longName":"C25613:C3262:C25548:C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E1A33BC-CD6D-5E87-E053-F662850A8DBF","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E1A33BC-CD7E-5E87-E053-F662850A8DBF","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-01","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the percentage of tum","type":"Preferred Question Text","description":"What is the percentage of tumor involvement?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"If Yes, What is the percentage of tumor involvement?","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Extent of bone marrow involvement:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E1A33BC-CDEF-5E87-E053-F662850A8DBF","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-26","modifiedBy":"MAESKEB","dateModified":"2021-11-08","changeDescription":"Workflow and Registration Status changes per Brenda Duggan; 05.16.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}